Hyponatremia at discharge as a predictor of 12-month clinical outcomes in hospital survivors after acute myocardial infarction

Myung Hwan Bae(Kyungpook National University Hospital), Shung Chull Chae(Kyungpook National University Hospital), Dong Heon Yang(Kyungpook National University Hospital), Yongkeun Cho(Kyungpook National University Hospital), Hun Sik Park(Kyungpook National University Hospital), Jae Hee Kim(Kyungpook National University), Jang Hoon Lee(Chungnam National University), Sun Hee Park(Kyungpook National University Hospital), Se Yong Jang(Kyungpook National University Hospital)
Heart and Vessels
June 2, 2016
10.1007/s00380-016-0854-6
Cited by 9

Related Papers

Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
|New England Journal of Medicine|2010|510
Stents versus Coronary-Artery Bypass Grafting for Left Main Coronary Artery Disease
|New England Journal of Medicine|2008|493
6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial
|The Lancet|2018|372
Clinical Impact of Intravascular Ultrasound–Guided Chronic Total Occlusion Intervention With Zotarolimus-Eluting Versus Biolimus-Eluting Stent Implantation
|Circulation Cardiovascular Interventions|2015|304
Long-Term Safety and Efficacy of Stenting Versus Coronary Artery Bypass Grafting for Unprotected Left Main Coronary Artery Disease
|Journal of the American College of Cardiology|2010|278